HEALTH

Rite Aid kicks off diabetes management campaign

BY Allison Cerra

CAMP HILL, Pa. Rite Aid is supporting the American Diabetes Association by hosting diabetes management events in its stores nationwide in line with American Diabetes Month in November.

More than 4,700 Rite Aid stores now through Dec. 25 will offer free 20-page diabetes guides at the pharmacy counters, as well as Diabetes Solutions Days, offering customers free blood-glucose, cholesterol, blood-pressure screenings and body mass index readings. Additionally, Rite Aid is offering the American Diabetes Association’s diabetes risk test online, and is offering Wellness+ customers the opportunity to earn 10 points when they take the test, in addition to $5 off their next purchase when they spend $30 on select diabetes products during the three-month campaign.

Rite Aid’s focus on diabetes management is part of its year-long commitment to patient health and wellness. Each year Rite Aid offers free information, answers and guidance on such health-and-wellness topics as weight management, heart health, allergy awareness, skin care and oral care.

“There’s a misconception that diabetes is life altering but not life threatening. Unfortunately, this isn’t true. Diabetes doubles the risk of heart attack or stroke and kills more Americans each year than breast cancer and AIDS combined,” said Robert Thompson, Rite Aid EVP pharmacy. “That’s why it’s so important for us to empower our patients and associates to help fight this devastating disease.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Pfizer recalls lot of ThermaCare HeatWraps Menstrual

BY Alaric DeArment

NEW YORK Pfizer’s over-the-counter division recalled one lot of a ThermaCare product over the possibility of leaks.

 

Pfizer Consumer Healthcare announced Friday the voluntary recall of lot number E06931 of its ThermaCare HeatWraps Menstrual product and notified the Food and Drug Administration.

 

 

The company said possible leaks in the wraps could cause skin injury, such as irritation and burning.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

AstraZeneca-Bristol drug just as effective as generic on market, trial results show

BY Alaric DeArment

STOCKHOLM An investigational diabetes drug works as well as a generic already on the market, according to results of a late-stage clinical trial announced Friday by AstraZeneca and Bristol-Myers Squibb.

 

The two companies said phase-3 trial results showed that their investigational drug dapagliflozin combined with the widely available generic metformin was as effective as glipizide combined with metformin, compared with metformin alone. In addition, patients in the dapagliflozin group experienced weight loss, compared with weight gain in those taking glipizide, as well as a reduced number of patients experiencing abnormally low blood sugar, known as hypoglycemia.

 

 

Results from the study were presented at the 46th annual meeting of the European Association for the Study of Diabetes.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?